Old CIC Events
05/03/2020
Understanding the transcriptome to treat KRAS-driven tumors: how far can we get?
Silve Vicent Cambra — Center for Applied Medical Research (CIMA) [Pamplona]
27/02/2020
Oesophageal mechanic switch dictates developmental transition towards homeostasis.
María Pilar Alcolea — University of Cambridge [Cambridge, UK]
13/02/2020
Mechanisms and consequences of large nuclear deformation : from microchannels to mammary tumors.
Matthieu Piel — Institut Curie de París
07/02/2020
CARRERA CIENTÍFICA EN INVESTIGACIÓN TRASLACIONAL.
Rafael Bañares — Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañón
06/02/2020
TARGETING RAS-PI3K SIGNALLING TO RE-EDUCATE THE STROMA OF RAS MUTANT LUNG CANCER.
Cristina Cuesta Apausa — Centro de Investigación del Cáncer (CIC-IBMCC)
30/01/2020
Rho GTPase signaling in skin tumor formation.
Cord Brakebusch — BRIC - University of Copenhagen [Copenhagen, Denmark]
29/01/2020
Tumor genomes shed light into somatic mutational processes and cancer vulnerabilities.
Nuria López-Bigas — IRB, Barcelona
23/01/2020
Which are the rules dictating the responsiveness between genes and enhancers?
Álvaro Rada Iglesias — Institute of Biomedicine & Biotechnology of Cantabria (IBBTEC) (IBBTEC) [Santander]
16/01/2020
Deciphering the role of 7-guanine tRNA methylation in Prostate Cancer progression.
Raquel García Vilchez — Centro de Investigación del Cáncer (CIC-IBMCC)
09/01/2020
Somatic structural variation and cancer.
José Manuel C. Tubio — CIMUS - University of Santiago de Compostela [Santiago de Compostela]
19/12/2019
The non-receptor tyrosine kinase ACK: signalling pathways and opportunities for therapeutic intervention.
Darerca Owen — University of Cambridge [Cambridge, UK]
17/12/2019
Defensa de tesis doctoral: Mecanismos autofágicos no convencionales implicados en el control del tráfico endocítico y la señalización celular.
Inmaculada Serramito Gómez — Centro de Investigación del Cáncer